Lumira Ventures, Discover how our venture capital initiativ
- Lumira Ventures, Discover how our venture capital initiatives are driving healthcare innovation and supporting groundbreaking companies. As a leading Canadian VC firm with offices in Toronto, Vancouver, and Montreal, we invest in groundbreaking healthcare solutions across North America. 6M over 5 rounds from 17 investors. 提供），Alveolus（由Merit Medical收购资产），Guava（由Millipore提供），Corus Pharma（由Gilead Sciences提供），以及Alexza的首次公开募股制药，Replidyne Lumira Ventures IV is a 2021 vintage venture capital fund managed by Lumira Ventures. Lumira Ventures is a leading Canadian life sciences venture capital firm, investing in biotech, medtech, and healthcare companies that are transforming global healthcare through innovation. Access Lumira Ventures's email format and Lumira Ventures staff directory for direct contact details of 21 employees. Founded in 1989, Lumira Ventures Toronto-based investment firm that focuses in biotech, biotherapeutics, and medical device companies that drive transformative healthcare innovation. We partner with mission-driven entrepreneurs to build transformative life sciences companies focused on developing and commercializing impactful products for patients. Lumira is actively raising the Cancer Breakthrough Fund, in partnership with the Terry Fox Foundation, in parallel with its core fund, Lumira Ventures Fund V. Dr. The fund is located in Toronto, Canada, and invests in the United States, and Canada. General Information Description Lumira Ventures V is a venture capital fund managed by Lumira Ventures. Stay informed on Lumira Ventures' latest investments, portfolio successes, and industry insights. , ("enGene" or the "Company"), a clinical-stage biotechnology company developing genetic Lumira Ventures is a North American healthcare venture capital firm with over two decades of experience investing in transformative biomedical companies. – 30 – About Lumira Ventures Lumira Ventures is a leading life sciences venture capital firm which has a long and deep track record of partnering with like-minded investors and mission driven entrepreneurs to build and scale transformative companies that positively impact patient lives, while generating strong returns for its investors. We partner with mission-driven entrepreneurs to build transformative life sciences companies focused on developing Since 1989, Lumira Ventures has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies located in Canada and the United States. Lumira Ventures is a leading North American life sciences investment firm dedicated to advancing healthcare innovation and enhancing patient outcomes. Founded in 2007, Lumira Ventures is a venture capital firm based in Toronto, Canada. Their latest funding round was of $8M on Jan 25, 2024 . Jenuth is a business executive with over 20 years of life science, IT and business development experience. $450M+ Invested: Over more than two decades, our firm has invested over $1B via multiple investment funds. ” Lumira also announced the formation of the Angelini Lumira Biosciences Fund (ALBF). D. Lumira executes a proven, differentiated investment strategy as The financing for the transaction includes Forbion Growth’s existing investment in FEAC Class A shares of $20 million and a PIPE investment, other private investment and non-redemption commitment of approximately $115 million, anchored by Forbion Growth, with the participation of new leading institutional investors including, among others Prior to joining Lumira Ventures in 2002, Mr. 在过去五年中，Lumira Ventures的合作伙伴帮助建立了50多家公司。 最近的成功包括收购投资组合公司，如Morphotek（由Eisai Co. Lumira Ventures and Amplitude Lead the Way for Supporting Canadian Biotech Seven Canadian biotech VCs have led financings rounds for at least three deals since 2017 with Lumira Ventures (8), Amplitude Ventures (5), and Noetic Fund (5) most frequently leading financings (Figure 2A). Lumira Ventures is proud to support Nocion Therapeutics alongside this distinguished group of syndicates including a strategic investor with deep domain expertise in inhaled respiratory Lumira VIP is an immersive 6–12-month program for Ph. The firm prefers to invest in biotechnology, medical technologies, digital health, and consumer healthcare solution sectors. TORONTO, ON / ACCESSWIRE / March 7, 2024 / Lumira Ventures, a life sciences investment firm dedicated to supporting healthcare innovation and patient impact, is proud to announce several Lumira Ventures is proud to introduce the newest cohort joining our Venture Innovation Program (VIP) for the 2024-2025 term. Lumira Ventures, Canada's largest life sciences venture capital firm, invests in healthcare innovators from early-stage to revenue-generating biotech, biotherapeutics, and medical devices. The firm focuses on investing in transformative life sciences companies, partnering with mission-driven founders to deliver exceptional returns for investors. The investment was co-led by Lumira Ventures and Alpha Wave Ventures, with participation from Roche Venture Fund, Pfizer (as part of the Pfizer Breakthrough Growth Initiative), Bristol Myers Squibb, Angelini Ventures, and the JDRF T1D Fund. Sound Blade Medical, Inc. To date, Lumira's companies have brought dozens of biomedical innovations to the market, impacting the lives of over 1 billion patients worldwide. Peter oversees the overall business operations of the firm and is a core part of the senior Lumira Ventures raises largest investment pot to date, nabbing $220M for life sciences bets By Ben Adams Jul 26, 2021 9:34am venture capital (VC) Canada Biotech -- Oversubscribed Series B led by Johnson & Johnson, with participation from S3 Ventures, Lumira Ventures, SV Health, and Deerfield -- Lumira Ventures, a leading North American life sciences investment firm dedicated to advancing healthcare innovation and enhancing patient outcomes, is pleased to announce the promotion of Suman Rao, Ph. Who are Lumira Ventures's competitors? Alternatives and possible competitors to Lumira Ventures may include Alumis, Vera Therapeutics, and Oculis. VIP aims to influence the pathways of students eager to get involved in the ecosystem and are deeply passionate about pushing the future of life sciences innovation forward. lumiraventures. , MBA, and MD students across Canada a unique opportunity to gain hands-on experience in life sciences venture capital and startups, nurturing the next generation of leaders, and contributing to the future […] Founder and Managing General Partner at Lumira Ventures · Peter joined MDS Capital in 2005 as President and CEO to oversee and manage the generational change resulting from the retirement of the founding CEO. Lumira Ventures is a Venture Capital & Private Equity company located in 141 Adelaide St W, Toronto, Ontario, CA with 21 employees. Investing in transformative biopharmaceutical and medical device companies across North America | Lumira Ventures is a leading healthcare and life sciences venture capital firm. Frequently Asked Questions Where is Lumira Ventures's headquarters? Lumira Ventures is located in Toronto, Ontario, Canada. Lumira Ventures III is a 2017 vintage venture capital fund managed by Lumira Ventures. Jacki is currently a partner with Lumira Ventures, Canada’s largest and most established venture firm focused on investing the life sciences sector in North America. Lumira Ventures, one of Canada’s top investors in private health sciences startups, is launching a hedge fund to bet on publicly traded companies it believes have been oversold during the sector Lumira Ventures III is a 2017 vintage venture capital fund managed by Lumira Ventures. We partner with mission-driven entrepreneurs to build transformative life sciences companies focused on developing Toronto-based Lumira Ventures has raised $276 million CAD ($220 million USD) for Fund IV, which Lumira claims is “the largest institutional life sciences venture capital fund ever raised in Canada. During that time, it completed eight exits and raised over US$800 million through initial public offerings and private financings. The financing was supported by Amplitude Ventures, Fonds de solidarité FTQ, Lumira Ventures, Investissement Québec, adMare BioInnovations, and CTI Life Sciences Fund. , a medical device company developing handheld ultrasound-guided histotripsy technology, announced today the successful closing of an oversubscribed US $16. The closing of the oversubscribed Lumira Ventures IV at US$220 million represents the largest fund Lumira has raised to date, and the largest institutional life sciences venture capital fund ever https://pipeseed. Jenuth’ investment focus is primarily on early to mid-stage private companies […] TORONTO, ON / ACCESSWIRE / June 7, 2022 / Lumira Ventures, a leading global healthcare venture capital firm, announced today the addition of David Novak to its investment team as a Venture Partner Lumira Ventures | 8,992 followers on LinkedIn. Lumira invests in best and/or first-in-class innovative healthcare companies that are primarily located in “secondary” geographies within North America. About Lumira Ventures Lumira Ventures is the largest and most active life sciences venture capital investor domiciled in Canada. Investors include Relay Ventures, DHVC and 15 others. Brunk was an entrepreneur in the life sciences sector, founding and serving in a variety of management and board capacities at several venture capital-funded companies. com) location in Ontario, Canada , revenue, industry and description. Lumira Ventures manages its activities from offices in Toronto, Montréal, Vancouver, and Boston. About Lumira Ventures Lumira Ventures is a leading life sciences venture capital firm which has a long and deep track record of partnering with like-minded investors and mission driven entrepreneurs to build and scale transformative companies that positively impact patient lives, while generating strong returns for its investors. View Lumira Ventures (www. Lumira Ventures IV is a 2021 vintage venture capital fund managed by Lumira Ventures. About Lumira Ventures Lumira Ventures is a North American healthcare venture capital firm with decades of experience investing in and building transformative biomedical companies. Established in 2007, the firm operates from offices in Toronto, Montréal, Vancouver, and Boston. com/investor/lumira-ventures-914543 Lumira Ventures is a North America healthcare venture capital firm that provides capital and operating expertise to life science companies developing innovative products that solve significant We are Lumira Ventures. Amzak Health and Lumira Ventures co-led the round, with participation from Invest Nova Scotia. Jan 9, 2026 · Explore Lumira Ventures' in-depth investor profile, including top investments, portfolio trends, leadership team, co-investors, and news updates. Building on Recent Regulatory Momentum Lumira Ventures is a later stage VC which partners & invests in best-in-class innovative biotherapeutic & medtech entrepreneurs building transformative companies. The VIP program offers Ph. In 2007 he led the management buyout of MDS Capital and rebranding it as Lumira Ventures. The fund will be located in Toronto, Ontario. Learn more about our approach and portfolio. 5 million Series A funding round. Founded in 2007, Lumira Ventures is a multi-stage life sciences investment firm with offices in Toronto, Montréal, Vancouver, and Boston. We back bold growth-stage entrepreneurs building frontier technology companies in massive markets. , MBA, and MD students across Canada who want to gain exposure to the life sciences venture capital and start-up ecosystem. 企查查为您提供Lumira Ventures投资机构详情查询，包括Lumira Ventures介绍、投资风格、投资项目、投资事件、投资团队以及Lumira Ventures最新投资动态等信息。 Talking point: Lumira’s fourth fund follows an active year and a half for the firm. We are a multi-stage investor that partners with mission-driven entrepreneurs and like-minded investors to build innovative healthcare companies. Lumira Ventures is a leading healthcare and life sciences venture capital firm. Lumira Ventures is Canada’s largest and most active healthcare venture capital firm that invests in North American companies developing innovative therapeutics and medical technologies whose products offer transformative improvements to patient health outcomes and meaningful reductions to the overall cost of healthcare delivery. $70B+ Cumulative Revenue of Portfolio Company Products: The 40+ products brought from discovery to market by our portfolio companies have generated over $60B of cumulative revenue. Find related and similar companies as well as employees by title and much more. - ALBF will complement Lumira’s US$220 million Fund IV, announced earlier this month. Explore Lumira Ventures investment portfolio and discover the innovative biotech, medtech, and life sciences companies we partner with. Canada's leading health care & life sciences venture capital firm with a 30-year reputation building companies across North America. Funds will be used to accelerate the development and clinical validation of its . ，CFA，生命科学投资副总裁，Fonds desolidaritéFTQ评论说：“我们自2007年以来一直支持Lumira。 我们很感激与我们对加强魁北克和加拿大生活充满热情的团体的合作科学领域，以及我们致力于为患者带来新的创新解决方案。 TORONTO, ON / ACCESSWIRE / November 2, 2023 / Lumira Ventures portfolio company enGene Holdings Inc. Talking point: Lumira’s fourth fund follows an active year and a half for the firm. Sc. $70B+ Cumulative Revenue of P… We back bold growth-stage entrepreneurs building frontier technology companies in massive markets. , to the role of Principal. Lumira invests in companies developing innovative biotherapeutics, medical technologies and consumer health solutions. Headquartered in Toronto, Ontario. Rome, 28 July 2021 - Angelini Pharma, part of the privately-owned Angelini Holding, and Lumira Ventures today announced the launch of the Angelini Lumira Biosciences Fund (ALBF). Swift Medical has raised a total funding of $59. We partner with mission-driven entrepreneurs building companies that harness rapidly evolving advancements in medicine to develop transformative products for patients while delivering strong financial Genevieve Guertin M. Lumira Ventures We are Lumira Ventures. Rooted in the Israeli ecosystem, we focus on scalable business models with a clear path to global leadership. 1fso, e5zb3, qims, wplkk, itn30, fwribl, vkn1p, easdd, qow6nc, zb4ejr,